20251 ⎘
Medicinal preparations containing organic active ingredients; Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
NOVEL CLASS OF COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE
#302THERAPEUTIC REGIMEN AND METHODS FOR TREATING OR AMELIORATING VISUAL DISORDERS ASSOCIATED WITH AN ENDOGENOUS RETINOID DEFICIENCY
#303ANTI-HEMAGGLUTININ ANTIBODIES AND METHODS OF USE
#304Marine organism-derived extract, compound, and medical composition having niche formation suppressing activity of leukemic stem cells
#305Cosmetic composition and the use thereof for regulating skin quality
#306METHOD OF TREATING INFLUENZA A
#30713-cis-RAMBA retinamides that degrade MNKs for treating cancer
#308Compositions and methods of use of phorbol esters in the treatment of neoplasms
#309Synergistic compositions and devices for gynecological procedures
#310Composition comprising a diindolylmethane and a retinoid to treat a skin condition
#311Pharmaceutical composition for oral administration comprising high concentration taxane
#312Method for treating an autoimmune neurological disease and/or neurodegenerative disease and pharmaceutical formulations for a liquid dosage form and a controlled release dosage form
#313Injectable pharmaceutical formulations of lefamulin
#314Methods and compositions for inhibition of polymerase
#315Treatment of HMGB1-mediated inflammation
#316COMPOSITIONS CONTAINING PHEROMONES FOR TREATING BEHAVIOURAL OR MEDICAL PROBLEMS LINKED TO THE STRESS OF NON-HUMAN MAMMALS
#317Composition preventing bacterial inflammation in monogastric animals
#318METHODS FOR TREATMENT OF ATHEROSCLEROSIS
#319COMPOSITIONS AND METHODS FOR INCREASED GLUCOSE UPTAKE AND FAT METABOLISM
#320METHODS FOR TREATMENT OF ATHEROSCLEROSIS
#321SKIN ADHESIVES, ANTIMICROBIAL COMPOSITIONS, ARTICLES, AND METHODS FOR THE USE THEREOF
#322Compositions and methods for mitigating methanogenesis in animals
#323CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#324Bioeffective krill oil compositions
#325PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY MICROBES
#326Supporting immunomodulatory agent
#327Compositions and methods for the treatment of fatty acid metabolism disorders
#328Compositions and methods for treating chronic inflammation and inflammatory diseases
#329Pharmaceutical composition for preventing or treating autoimmune diseases comprising cedrol or derivatives thereof, or pharmaceutically acceptable salts thereof
#330Therapeutic Compositions
#331Cosmetic composition for preventing or ameliorating hypersensitive skin comprising cedrol or derivatives thereof, or pharmaceutically acceptable salts thereof
#332Recovery and processing of human embryos formed in vivo
#333Self-emulsifying formulations of DIM-related indoles
#334Adhesive polymer and medical adhesive patch
#335INFLUENZA VIRUS AND TYPE 1 DIABETES
#336METHODS OF CANCER TREATMENT
#337CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#338BIOEFFECTIVE KRILL OIL COMPOSITIONS
#339Methods for controlling the spread of dirofilariosis
#340Use of 1-phenyl-3-dimethylaminopropane Compounds for Treating Rheumatoid Pain
#341COMPOSITION FOR TREATING AND PREVENTING VIRAL INFECTIONS
#342Drug delivery devices for delivery of ocular therapeutic agents
#343Topical compositions comprising fipronil and permethrin and methods of use
#344PHARMACEUTICAL FORMULATION COMPRISING ONE OR MORE FUMARIC ACID ESTERS IN AN EROSION MATRIX
#345Compositions and methods of use of phorbol esters in the treatment of neoplasms
#346Methods for treating dry eye
#3471-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors
#348PHARMACEUTICAL COMPOSITIONS COMPRISING DANIRIXIN FOR TREATING INFECTIOUS DISEASES
#349NEURODEGENERATIVE DISORDERS AND METHODS OF TREATMENT AND DIAGNOSIS THEREOF
#350PREVENTION OF METASTASIS AND RECURRENCE AFTER PRIMARY CANCER TREATMENT
#351Bioeffective krill oil compositions
#352METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING LYMPHOCYTE PROLIFERATION IN A SUBJECT IN NEED THEREOF
#353Hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them
#354Semiochemical compositions to reduce social conflicts with cats
#355METHOD FOR STRATIFICATION OF MELANOMA PATIENTS BY DETERMINATION OF OXYGEN CONSUMPTION, PPARGC1A, PPARGC1B AND MITF LEVELS
#356Self-emulsifying formulations of DIM-related indoles
#357Inhibitors of influenza viruses replication
#358Vitamin A for parenteral administration
#3591-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors
#360FORMULATIONS AND USES OF RETINOIC ACID RECEPTOR SELECTIVE AGONISTS
#361Nasolacrimal drainage system implants for drug therapy
#362METHODS FOR INHIBITING MUSCLE ATROPHY
#363Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one Chamomilla plant for the treatment of cancer
#364METHOD OF ENHANCING HAIR GROWTH
#365CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#366METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION
#367Cyclohexenyl compounds, compositions comprising them and uses thereof
#368METHODS AND SYSTEMS OF POSITIONING AN IMPLANT
#369Compounds and methods for treating influenza
#370Compositions and methods for the treatment of fatty acid metabolism disorders
#371Allosteric activators for treatment of phenylketonuria
#372Compositions and methods for inhibiting hair growth
#373Naphthoquinone Compounds and Methods for Preparing the Same
#374EXPANDABLE MEDICAL DEVICE AND METHOD OF USE
#375IMPLANTABLE DRUG ELUTING SYSTEM AND METHOD OF USE
#376Antiviral compositions for treating the flu
#377Bicyclic analgesic compounds
#378Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
#379Methods of preventing secondary infections
#380CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#381Recovery and processing of human embryos formed in vivo
#382Antiviral treatments
#383Compositions of jasmonate compounds and methods of use
#384Compositions and methods for treating cardiovascular diseases
#385Soothing pro-pheromonal composition for mammals
#386PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9
#387Parasiticidal compositions comprising fipronil at high concentrations
#388Reduction in CPC taste aversion by reducing CPC activation of TRPA1, TPRV1, or both
#389Use of 1-phenyl-3-dimethylaminopropane Compounds for Treating Rheumatoid Pain
#390ANTI-INFLUENZA B VIRUS HEMAGGLUTININ ANTIBODIES AND METHODS OF USE
#3911-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors
#392COMBINATION
#393Non-irritating, non-blurring, photostable ophthalmic sunscreen composition
#394Misoprostol Dispersible Tablet
#395PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY MICROBES
#396HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
#397Oseltamivir Compositions
#398Hepatitis B antiviral agents
#399Cannabigerol derivatives
#400Methods for the Selective Treatment of Tumors by Calcium-Mediated Induction of Apoptosis
#401Bioeffective krill oil compositions
#402Supporting immunomodulatory agent
#403MEK INHIBITORS IN THE TREATMENT OF VIRUS DISEASES
#404Medicine dispensing system
#405Misoprostol dispersible tablet
#406Composition for preventing the occurrence of cardiovascular event in multiple risk patient
#407Nasolacrimal drainage system implants for drug therapy
#408Influenza A H7N9 virus therapies
#409USE OF A FEED COMPOSITION FOR REDUCING METHANE EMISSION IN RUMINANTS, AND/OR TO IMPROVE RUMINANT PERFORMANCE
#410PHARMACEUTICAL COMPOSITIONS COMPRISING DANIRIXIN FOR TREATING INFECTIOUS DISEASES
#411METHODS FOR ASSESSING RESPONSIVENESS TO ASTHMA TREATMENT BASED ON VNN-1 EXPRESSION AND PROMOTER METHYLATION
#412Dry-powder peptide medicament
#413Therapeutic regimen and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency
#414Compositions and methods of use of phorbol esters for the treatment of stroke
#415Compositions and methods relating to proliferative diseases
#416HIGH PENETRATION PRODRUG COMPOSITIONS OF RETINOIDS AND RETINOID-RELATED COMPOUNDS
#417Methods for treating occular irritation involving tearing by administering modulators of TRPM8
#418Method for treating vaginal dryness by administering transient receptor potential cation channel subfamily M member 8 (TRPM8) receptor agonists
#419Methods and compositions for inhibition of polymerase
#420Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
#421Outpatient modified rapid detoxification for addiction to alcohol and drugs
#422Self-emulsifying formulations of DIM-related indoles
#423Retinal derivatives and methods for the use thereof for the treatment of visual disorders
#4241-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitors
#425Kallikrein 7 inhibitors
#426MUSK COMPOSITIONS AND METHODS OF USE THEREOF
#427Musk compositions and methods of use thereof
#428Bicyclic analgesic compounds
#429METHODS AND COMPOSITIONS FOR ERADICATING LEUKEMIC CELLS
#430Composition comprising a diindolylmethane and a retinoid to treat a skin condition
#431Topical compositions comprising fipronil and permethrin and methods of use
#432Inhibitors of influenza viruses replication
#433Bicyclic analgesic compounds
#434FORMULATIONS OF JASMONATES AND NANOCARRIERS OR MICROCARRIERS
#435Use of Sigma-1 receptor agonist compounds
#436Methods and compositions for preventing and treating auditory dysfunctions
#437Compositions and methods of use of phorbol esters in the treatment of neoplasms
#438Methods for the treatment and prevention of age-related retinal dysfunction
#439Compositions and methods for treating cardiovascular diseases
#440Use of cyclohexanol derivatives as antimicrobial active compounds
#441Topical formulations of tellurium-containing compounds
#442Reduction in CPC taste aversion by reducing CPC activation of TRPA1, TPRV1, or both
#443Compositions and methods for treating chronic inflammation and inflammatory diseases
#444Compositions and methods for treating chronic inflammation and inflammatory diseases
#445Aza-pyridone compounds and uses thereof
#446Neurodegenerative disorders and methods of treatment and diagnosis thereof
#447Therapeutic compositions
#448Therapeutic compositions
#449Therapeutic compositions
#450Therapeutic compositions
#451Esters of short chains fatty acids for use in the treatment of immunogenic disorders
#452Methods for inhibiting muscle atrophy
#453Formulations Comprising Idebenone, N-Acetyl-S-Farnesyl-L-Cysteine and Ergothioneine and Uses Thereof
#454Compounds useful in the treatment of neoplastic diseases
#455Novel Uses of Neuraminidase Inhibitors in Infectious Diseases
#456Lipid compositions
#457Aza-pyridone compounds and uses thereof
#458Compounds and methods for treating influenza
#459HNF4-alpha ANTAGONIST AND USE THEREOF
#460Human antibodies to influenza hemagglutinin
#461Dermal compositions
#462Anti-hemagglutinin antibodies and methods of use
#463Ophthalmic compositions containing a nitric oxide donor
#464METALLO-B-LACTAMASE INHIBITORS
#465Quinone based nitric oxide donating compounds for ophthalmic use
#466FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES
#467Oral pharmaceutical composition comprising oseltamivir and method of preparing the same
#468ORALLY-DISINTEGRATING OSELTAMIVIR TABLET AND METHOD FOR PREPARING THE SAME
#469Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
#470Compositions And Methods Of Use Of Phorbol Esters
#471Drug delivery devices for delivery of ocular therapeutic agents
#472Ocular system with anchoring implant and therapeutic agent
#473Method of reducing appetite in a human subject comprising administering krill oil composition
#474Vector delivery-based microbicides
#475Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
#476NUTRITIONAL COMPOSITION AND METHOD OF MANUFACTURE
#477Method for preventing or treating neurodegenerative diseases
#478Organonitro thioether compounds and medical uses thereof
#479Long-acting semi-solid lipid formulations
#480Methods, uses and compositions of Tie2 agonists
#481Composition comprising at least two influenza A virus-neutralizing-binding molecules
#482Usage of mycophenolate mofetil or salt thereof in preparing drug for resisting against influenza virus
#483METHODS AND PHARMACEUTICAL COMPOSITIONS (CTPS 1 INHIBITORS, E.G. NORLEUCINE) FOR INHIBITING T CELL PROLIFERATION IN A SUBJECT IN NEED THEREOF
#484Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
#485Micronutrient formulation in electronic cigarettes
#486METHOD FOR PROMOTING INSULIN SECRETION BY USING COMPOUNDS AND EXTRACTS ISOLATED FROM ANTRODIA CAMPHORATA
#487FORMULATIONS AND USES OF RETINOIC ACID RECEPTOR SELECTIVE AGONISTS
#488Thromboxane receptor antagonists
#489Bicyclic analgesic compounds
#4901-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors
#491Local topical administration formulations containing indoxacarb
#492MISOPROSTOL DISPERSIBLE TABLET
#493Scleral and conjuctival implants for drug therapy
#494Compositions And Methods Of Use Of Phorbol Esters In The Treatment Of Neoplasms
#495Composition and methods used during anti-HIV treatment
#496Recovery and processing of human embryos formed in vivo
#497Recovery and processing of human embryos formed in vivo
#498Recovery and processing of human embryos formed in vivo
#499COMPOSITIONS FOR PROMOTION OF WOUND HEALING AND/OR SCAR REDUCTION
#500Use of TRMP8 for treating opthalmic diseases or conditions involving tearing
#501Method for the treatment of hypercholesterolemia
#502Method for the treatment of hypercholesterolemia
#503Gummy compositions for nutritional supplementation
#504INFLUENZA VIRUS AND TYPE 1 DIABETES
#505Methods and compositions for treatment of lipid storage disorders
#506GUMMY COMPOSITIONS FOR NUTRITIONAL SUPPLEMENTATION
#507Composition of enhancing hair growth
#508Methods for treatment of atherosclerosis
#509Anti-influenza B virus hemagglutinin antibodies and methods of use
#510Compounds for Reducing Glucocorticoids, and Methods of Treatment Thereof
#511USE OF ELECTROPHILIC COMPOUNDS FOR INDUCING PLATELET PRODUCTION OR MAINTAINING PLATELET FUNCTION
#512Anti-hemagglutinin antibodies and methods of use
#513Cosmetic or dermatological preparation for prophylaxis and/or treatment of atopic dermatitis
#514Compositions and methods for inhibiting hair growth
#515Compositions and methods for inhibiting hair growth
#5161-pyrazolyl-3-((4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors
#517Compounds and methods for treating influenza
#518Esters of short chains fatty acids for use in the treatment of immunogenic disorders
#519MEK inhibitors in the treatment of virus diseases
#520Method for treating triple-negative breast cancer using AMPI-109
#521Methods for treatment of atherosclerosis
#522PHARMACEUTICAL COMPOSITION ADAPTED FOR ORAL ADMINISTRATION AND THE PROCESS FOR ITS PREPARATION, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, BASED ON AN INTESTINAL MOTILITY MODIFIER AND a-D-GALACTOSIDASE
#523CHEMICAL SUPPRESSORS OF NEUROTOXICITY IN SYNUCLEINOPATHIC DISEASES
#524Compositions and methods for the treatment of moderate to severe pain
#525Treatment of osteoporosis
#526Compositions of jasmonate compounds and methods of use
#527Compositions and methods for treating macular degeneration
#528Method of topically treating actinic keratosis with ingenol mebutate cycle therapy
#529Pharmaceutical compositions comprising glitazones and Nrf2 activators
#530Pharmaceutical composition for treating wounds or revitalizing skin comprising extracts, fractions thereof or diterpene compounds separated from the fractions as active ingredient
#531Cancer-related extracellular matrix signatures and related methods and products
#532Compositions And Methods Of Use Of Phorbol Esters In The Treatment Of Neoplasms
#533Use of Neu1 sialidase inhibitors in the treatment of cancer
#534Compositions and methods for treating chronic inflammation and inflammatory diseases
#535Compositions for treating cardiovascular diseases
#536Methods and compositions for inhibition of polymerase
#537THERAPEUTIC REGIMENS AND METHODS FOR IMPROVING VISUAL FUNCTION IN VISUAL DISORDERS ASSOCIATED WITH AN ENDOGENOUS RETINOID DEFICIENCY
#538Method of treating overactive bladder, not due to cancer, by administering at least one jasmonate
#539Phorbol type diterpene compound, pharmaceutical composition for treatment or prevention of viral infectious diseases including same
#540Esters for treatment of ocular inflammatory conditions
#541COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLUENZA
#542Therapeutic compositions
#543Amooranin compounds and analogs thereof and related methods of use
#544Organonitro thioether compounds and medical uses thereof
#545Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
#546Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
#547METHOD FOR TREATING WOUNDS AND TISSUE REPAIR
#548Use of cyclohexanol derivatives as antimicrobial active compounds
#549GEL COMPOSITIONS
#550Compositions and methods relating to proliferative diseases
#551PKC activators and combinations thereof
#552Antiviral treatments
#553Prophylactic and/or therapeutic agent for cardiovascular complications of diabetes
#554Pharmaceutical compositions of dimethyl fumarate
#555Bicyclic analgesic compounds
#556Prophylactic agent for chronic kidney disease
#557PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY MICROBES
#5581-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors
#559Anti-hemagglutinin antibodies and methods of use
#560Pharmaceutical compositions having desirable bioavailability
#561Nasolacrimal drainage system implants for drug therapy
#562Composition Comprising Retinol, a Precursor or a Reaction Product of it and a Plant Extract from at least one Chamomilla Plant for the Treatment of Cancer
#563Methods for lowering blood glucose
#564Pharmaceutical Formulation Comprising Compounds of the Jasmonate Family
#565Cyclohexylamines
#566Compositions and methods of use of phorbol esters
#567Pharmaceutical compositions comprising human antibodies to PCSK9
#568Methods and compositions for localized delivery of agents to virally infected cells and tissues
#569METHOD OF SELECTING THERAPEUTIC INDICATIONS
#570Drug delivery methods, structures, and compositions for nasolacrimal system
#571Anti-hemagglutinin antibodies and methods of use
#572Method of reducing cholesterol levels using a human anti-PCSK9 antibody
#573Novel Uses of Neuraminidase Inhibitors in Infectious Diseases
#574Composition comprising a diindolylmethane and a retinoid to treat a skin condition
#575Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma
#576Nitrooxy alkanoic acids and derivatives thereof in feed for reducing methane emission in ruminants, and/or to improve ruminant performance
#577Pharmaceutical Compositions Comprising Capsaicin Esters for Treating Pain and Cold Sores
#578Water-swellable polymers
#579Compositions And Methods Of Use Of Phorbol Esters In The Treatment Of Neoplasms
#580CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#581Use of a feed composition for reducing methane emission in ruminants, and/or to improve ruminant performance
#582Pyrimidinone compounds and methods for treating influenza
#583Formulations for enhanced bioavailability of orally administered polar agents
#584INTRACELLULAR CALCIUM MODULATION FOR CANCER TREATMENT
#585Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
#586Nitric oxide releasing amino acid ester compound, composition and method of use
#587Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
#588METHOD FOR PREVENTING OR TREATING ARRHYTHMIA, METHOD FOR PREVENTING OR TREATING ATRIAL FIBRILLATION, MODEL OF SUSTAINED ATRIAL FIBRILLATION, METHOD FOR PRODUCING THE MODEL, AND METHOD FOR SCREENING FOR ATRIAL FIBRILLATION INHIBITOR
#589Composition comprising Retinol, a precursor or a reaction product of it and a plant extract from at least one Chamomilla plant for the treatment of cancer
#590COMBINATION OF SULFONAMIDE COMPOUND AND TAFLUPROST
#591Compositions and methods of use of phorbol esters in the treatment of neoplasms
#592AGENT FOR DELAYING DIGESTION AND ABSORPTION OF LIPID
#593STABLE COMPOSITION COMPRISING CHOLESTEROL-LOWERING AGENTS, ANTIHYPERTENSIVE AGENTS AND ANTIPLATLET AGENTS
#594Ingenols for treating seborrheic keratosis
#5953-acyl-ingenols II
#596Methods and compositions for preventing and treating auditory dysfunctions
#597LOW TOXICITY TOPICAL ACTIVE AGENT DELIVERY SYSTEM
#598Pharmaceutical compositions comprising Fesoterodine
#599EYE DROP PREPARATION COMPRISING LATANOPROST
#600Combination of an HMG-CoA reductase inhibitor and a farnesyl-pyrophosphate synthase inhibitor for the treatment of diseases related to the persistence and/or accumulation of prenylated proteins